CIDARA THERAPEUTICS INC (CDTX) Stock Cash Flow
NASDAQ:CDTX - Nasdaq - US1717572069 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -182.98M | -169.83M | -22.93M | -29.80M | -42.47M | |||
| Depreciation Amortization | 226.00K | 233.00K | 118.00K | 143.00K | 189.00K | |||
| Change In Working Capital | -11.72M | -13.93M | -3.92M | -3.43M | 14.44M | |||
| Interest Paid | N/A | N/A | 0.00 | 40.00K | 228.00K | |||
| Other non cash items | 2.63M | 6.99M | 4.30M | 4.62M | 2.61M | |||
| OPERATING CASH FLOW | -191.84M | -176.53M | -22.43M | -28.47M | -25.23M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -106.00K | -129.00K | -505.00K | -118.00K | -41.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | 79.00K | -129.00K | -505.00K | -118.00K | -41.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -276.00K | -276.00K | 0.00 | -2.59M | -4.44M | |||
| Stock Issued/Repurchased | 337.50M | 337.38M | 25.98M | 1.64M | 49.04M | |||
| Other Financing Activity | 4.00K | -39.00K | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 337.23M | 337.06M | 25.98M | -951.00K | 44.60M | |||
| CHANGE IN CASH | 145.47M | 160.40M | 3.05M | -29.54M | 19.32M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -191.84M | -176.53M | -22.43M | -28.47M | -25.23M | |||
| Capital Expenditure | -106.00K | -129.00K | -505.00K | -118.00K | -41.00K | |||
| FREE CASH FLOW | -191.94M | -176.66M | -22.94M | -28.59M | -25.27M | |||
All data in USD